Skip to main content

. 1994 Mar 12;308(6930):695–696. doi: 10.1136/bmj.308.6930.695

Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Trent Regional Hepatitis C Virus Study Group.

W L Irving ¹, K R Neal ¹, J C Underwood ¹, P N Simmonds ¹, V James ¹

PMCID: PMC2539416 PMID: 8142794

696

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992 Dec 31;327(27):1899–1905. doi: 10.1056/NEJM199212313272702. [DOI] [PubMed] [Google Scholar]
Garson J. A., Ring C. J., Tuke P. W. Improvement of HCV genome detection with "short" PCR products. Lancet. 1991 Dec 7;338(8780):1466–1467. doi: 10.1016/0140-6736(91)92775-w. [DOI] [PubMed] [Google Scholar]
Irving W. L., Day S., Bennett D., Eglin R. P., Flanagan P., Nuttall P., James V. Use of anti-GOR testing in the screening of blood donors for hepatitis C virus infection. Vox Sang. 1993;65(1):38–41. doi: 10.1111/j.1423-0410.1993.tb04522.x. [DOI] [PubMed] [Google Scholar]
Makris M., Preston F. E., Triger D. R., Underwood J. C., Westlake L., Adelman M. I. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood. 1991 Oct 1;78(7):1672–1677. [PubMed] [Google Scholar]
Simmonds P., Rose K. A., Graham S., Chan S. W., McOmish F., Dow B. C., Follett E. A., Yap P. L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol. 1993 Jun;31(6):1493–1503. doi: 10.1128/jcm.31.6.1493-1503.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES